1. Transforming Cardiotoxicity Detection in Cancer Therapies: The Promise of MicroRNAs as Precision Biomarkers
   Isabel Moscoso et al, 2024, International Journal of Molecular Sciences CrossRef
2. Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model
   Michaela Adamcova et al, 2024, Frontiers in Pharmacology CrossRef
3. Identification of miRNA–mRNA regulatory network associated with the glutamatergic system in post-traumatic epilepsy rats
   Xiaoyuan Zhang et al, 2022, Frontiers in Neurology CrossRef
4. Identification of autophagy-related signatures in doxorubicin-induced cardiotoxicity
   Haiyan Wu et al, 2024, Toxicology and Applied Pharmacology CrossRef
5. Deciphering the roles of cellular and extracellular non-coding RNAs in chemotherapy-induced cardiotoxicity
   Pan Feng et al, 2024, Molecular and Cellular Biochemistry CrossRef
6. MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
   Ziyu Kuang et al, 2023, Biomolecules CrossRef
7. Sclerostin is involved in osteogenic transdifferentiation of vascular smooth muscle cells in chronic kidney disease-associated vascular calcification with non-canonical Wnt signaling
   Qiong Xiao et al, 2022, Renal Failure CrossRef
8. A CircRNA–miRNA–mRNA Network for Exploring Doxorubicin- and Myocet-Induced Cardiotoxicity in a Translational Porcine Model
   Julia Mester-Tonczar et al, 2023, Biomolecules CrossRef
9. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
   Ippei Kawano et al, 2022, Frontiers in Pharmacology CrossRef
10. CircHDAC9 regulates myocardial ischemia-reperfusion injury via miR-671-5p/SOX4 signaling axis
    Qin Liu et al, 2024, The American Journal of the Medical Sciences CrossRef